Inotuzumab ozogamicin (Besponsa) Protocol

Curated Five Minute Hematology reference for Inotuzumab ozogamicin (Besponsa). Open the approved protocol in 5MH Tools.

Acute Lymphoblastic Leukemia Single-agent therapy

Open protocol

Continue to the reviewed 5MH Tools protocol reference for regimen details, schedule, supportive-care context, evidence and source transparency.

Protocol reference Inotuzumab ozogamicin (Besponsa) · Acute Lymphoblastic Leukemia · Single-agent therapy · v1.2.3
Aliases Besponsa, inotuzumab, INO
Medical review Reviewed 2026-10-07 · Duration follows the regimen-specific treatment strategy
Protocol type Single therapeutic agent with its dosing, administration, monitoring, and supportive care.
Source transparency Evidence references are available in the approved 5MH protocol.